Your browser doesn't support javascript.
loading
Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer.
Del Rivero, Jaydira; Edgerly, Maureen; Ward, Jean; Madan, Ravi A; Balasubramaniam, Sanjeeve; Fojo, Tito; Gramza, Ann W.
Afiliação
  • Del Rivero J; Medical Oncology Service/Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Edgerly M; Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Ward J; Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
  • Madan RA; Genitourinary Malignancies, Branch Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Balasubramaniam S; Division of Oncology Products 1, OHOP, CDER, FDA, Silver Spring, Maryland, USA.
  • Fojo T; Department of Medicine, Division of Hematology Oncology, Columbia University Medical Center, New York New York, USA atf2116@columbia.edu.
  • Gramza AW; James J. Peters VA Medical Center, Bronx, New York, USA.
Oncologist ; 24(1): 16-e14, 2019 01.
Article em En | MEDLINE | ID: mdl-30297385
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Quinazolinas / Neoplasias da Glândula Tireoide / Carcinoma Neuroendócrino / Bortezomib / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Quinazolinas / Neoplasias da Glândula Tireoide / Carcinoma Neuroendócrino / Bortezomib / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos